The new TriLipo technology impressed me more than any other non-invasive treatment I have seen so far. With the patients I’ve treated, we attained excellent immediate and long-lasting results.
(PRWEB) November 08, 2011
Pollogen Ltd., a leader in medical aesthetics, will participate in Asia’s largest aesthetic show - CosmoProf Asia, held in Hong-Kong on November 9-11, 2011. Together with its Hong-Kong distributor, Bio-Therapeutic Computers Ltd., Pollogen’s products will be displayed in booth 3E-G1A.
The TriLipo MED procedure was launched in Hong-Kong in September 2011 and has been very well received by the professional aesthetic community. The procedure is the first of its kind since it allows practitioners to treat all four layers of the skin - the epidermis, dermis, hypodermis and muscle, using a single device. The Maximus platform houses three unique technologies - TriLipo Radiofrequency (RF), TriLipo dynamic muscle activation (DMA) and TriFractional which complement each other to deliver superior anti-aging results. The exceptional treatment flexibility and variety available using the Maximus platform makes it one of the most cost-effective devices in the market.
When treating the face, the TriLipo MED procedure has been clinically proven to reduce wrinkles and fine lines, treat scars and pigmentation and tighten the skin. When treating the body, the TriLipo MED effectively reduces body circumference and cellulite as well as tones and firms the skin. A key benefit of the TriLipo MED procedure is its ability to treat delicate areas such as the décolleté, neck and hands.
Jonathan Yu, M.D., a leading physician from the Philippines who has been using Pollogen’s TriLipo technology stated: “Reaching superior body contouring and facial rejuvenation results is of the utmost importance to my patients and me. The new TriLipo technology impressed me more than any other non-invasive treatment I have seen so far. With the patients I’ve treated, we attained excellent immediate and long-lasting results. "
Pollogen’s CEO, Mr. Amichai Bar Nir stated: “Pollogen has participated in the CosmoProf Asia – Asia’s largest beauty show for 5 years in a row. Pollogen’s high-end, high-technology products have been very well received in Asia and we are confident that the Asian market will quickly adopt the TriLipo MED procedure. The TriLipo MED procedure can be performed on all skin types and colors - factors which are very important in the Asian market.“
Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for circumference reduction, cellulite reduction and skin tightening. The company’s medical aesthetic devices, Maximus, apollo, and regen XL offer customers clinically-proven, safe and effective anti-aging lunchtime beauty treatments that deliver immediate and long-lasting results. With a distribution network in over 60 countries, Pollogen is providing innovative solutions to medical professionals globally.